Hbk Sorce Advisory LLC Electro Core, Inc. Transaction History

Hbk Sorce Advisory LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.21 - $5.63 $10,348 - $277,440	49,279 Added 100.0%	98,558 $25,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $6.75 $22,668 - $332,633	49,279 New	49,279 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $13,305 - $30,060	-49,279 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$0.8 - $2.33 $1,600 - $4,660	-2,000 Reduced 3.9%	49,279 $85,000
Q4 2019 Feb 13, 2020	BUY	$1.23 - $2.67 $63,073 - $136,914	51,279 New	51,279 $82,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $503M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.